OGEN INTELLIGENCE Pharmaceutical Company is located in Dubai, Emirate. OGEN designed and planned on research and development of highest international novel formulation research using Artificial intelligence, Machine Learning, Dynamic Simulations and Molecular Modeling in drug design.

Controlled release formulation based on microsphere, novel synthesized polymer, natural backbone have been fundamental research in R&D.

On the basis of application, the AI and computational approaches in drug discovery is planned into oncology, controlled release formulations, chemotherapeutic side effect drugs, neurodegenerative diseases, specific supplements, metabolic and infectious drugs in our company.

AI & ML can able to discover drugs for complex diseases and improve the science of pharmaceutical market players on providing AI-based platforms for novel industrial formulations.